Alder BioPharmaceuticals® to Present at Two Upcoming May Investor Conferences
15 May 2019 - 6:05AM
Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical
company focused on developing novel therapeutic antibodies for the
treatment of migraine, today announced that members of the
management team will provide a business overview and update at the
2019 RBC Capital Markets Global Healthcare Conference at 9:30 am ET
on Tuesday, May 21, 2019 and at the UBS Global Healthcare
Conference at 10:00 am ET on Wednesday, May 22, 2019, both in New
York, NY.
The presentations will be webcast live on the Events &
Presentations page of the Investors section of Alder's website
at http://www.alderbio.com, or by following the links below in
your web browser. An archived replay of each webcast will be
available on Alder's website for at least 30 days after each live
event concludes.
- RBC:
http://www.veracast.com/webcasts/rbc/healthcare2019/15314267548.cfm
- UBS:
https://cc.talkpoint.com/ubsx001/052019a_as/?entity=49_QLELLE8
About Alder BioPharmaceuticals, Inc.Alder
BioPharmaceuticals is a clinical-stage biopharmaceutical
company focused on transforming migraine treatment through the
discovery, development and commercialization of novel therapeutic
antibodies. Alder’s lead product candidate, eptinezumab, is an
investigational monoclonal antibody (mAb) delivered by infusion
that inhibits the CGRP for the prevention of migraine. If approved
by the U.S. Food and Drug Administration, it will be the first
quarterly, anti-CGRP infusion therapy for migraine
prevention. Alder is also developing ALD1910, a preclinical
mAb that inhibits pituitary adenylate cyclase-activating
polypeptide-38 (PACAP-38) for migraine prevention. For more
information, please visit www.alderbio.com.
Investor Relations
Contact:
Michael SchaffzinStern Investor Relations,
Inc.212.362.1200michael@sternir.com
Media Contact: Ashley
CadleTogoRuna.cadle@togorun.com310.463.0143
Alder BioPharmaceuticals (NASDAQ:ALDR)
Historical Stock Chart
From Apr 2024 to May 2024
Alder BioPharmaceuticals (NASDAQ:ALDR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Alder BioPharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles